Journal of Medical Economics, Volume 2, Issue 1-4 (1999)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Journal of Medical Economics, Volume 2, Issue 1-4 (1999)

See all volumes and issues
Vol 27, 2024 Vol 26, 2023 Vol 25, 2022 Vol 24, 2021 Vol 23, 2020 Vol 22, 2019 Vol 21, 2018 Vol 20, 2017 Vol 19, 2016 Vol 18, 2015 Vol 17, 2014 Vol 16, 2013 Vol 15, 2012 Vol 14, 2011 Vol 13, 2010 Vol 12, 2009 Vol 11, 2008 Vol 10, 2007 Vol 9, 2006 Vol 8, 2005 Vol 7, 2004 Vol 6, 2003 Vol 5, 2002 Vol 4, 2001 Vol 3, 2000 Volume 2, 1999 Vol 1, 1998
Download citations Download PDFs Download issue

Research Article

Article
Modelling the long-term cost-effectiveness of riluzole for the treatment of amyotrophic lateral sclerosis
Manouche Tavakoli, Huw T O Davies & M Malek
Pages: 1-14
Published online: 02 Dec 2008
AbstractforModelling the long-term cost-effectiveness of riluzole for the treatment of amyotrophic lateral sclerosis | References | PDF (88.7 KB)
  • 215 Views
  • 3 CrossRef citations
  • 0Altmetric
Free Access
Article
Cost of managing constipation among terminally ill cancer patients treated with transdermal fentanyl and 12 hour sustained-release morphine in Canada
TN Flynn & JF Guest
Pages: 15-32
Published online: 02 Dec 2008
AbstractforCost of managing constipation among terminally ill cancer patients treated with transdermal fentanyl and 12 hour sustained-release morphine in Canada | References | PDF (100.5 KB)
  • 63 Views
  • 4 CrossRef citations
  • 0Altmetric
Free Access
Article
Cost-effectiveness implications of increased survival with anastrozole in the treatment of advanced breast cancer
M Drummond, E Thompson, A Howell, W Jonat, A Buzdar & J Brown
Pages: 33-43
Published online: 02 Dec 2008
AbstractforCost-effectiveness implications of increased survival with anastrozole in the treatment of advanced breast cancer | References | PDF (78.4 KB)
  • 74 Views
  • 8 CrossRef citations
  • 0Altmetric
Free Access
Article
Cost of NSAID adverse effects to the UK National Health Service
R Andrew Moore DSc & Ceri J Phillips PhD
Pages: 45-55
Published online: 02 Dec 2008
AbstractforCost of NSAID adverse effects to the UK National Health Service | References | PDF (66.6 KB)
  • 429 Views
  • 51 CrossRef citations
  • 0Altmetric
Free Access
Article
The economic advantages of response in the treatment of advanced breast cancer
Ruth E Brown MS MSHA & Anita Burrell MA MBA
Pages: 57-63
Published online: 02 Dec 2008
AbstractforThe economic advantages of response in the treatment of advanced breast cancer | References | PDF (51.3 KB)
  • 33 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access
Article
Cost-effectiveness of Viridal Duo compared to MUSE and Viagra in the treatment of erectile dysfunction in the UK - a preliminary model
Jonathan M Plumb MSc & Julian F Guest PhD
Pages: 65-83
Published online: 02 Dec 2008
AbstractforCost-effectiveness of Viridal Duo compared to MUSE and Viagra in the treatment of erectile dysfunction in the UK - a preliminary model | References | PDF (152 KB)
  • 223 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access
Article
Modelling the cost-effectiveness of nevirapine triple combination therapy and dual combination therapy for the treatment of HIV disease in the United Kingdom
AK Biddle PhD & KN Simpson DrPH
Pages: 85-105
Published online: 02 Dec 2008
AbstractforModelling the cost-effectiveness of nevirapine triple combination therapy and dual combination therapy for the treatment of HIV disease in the United Kingdom | References | PDF (119.2 KB)
  • 82 Views
  • 3 CrossRef citations
  • 0Altmetric
Free Access
Article
Therapy Cost 2000: a computer model for pharmacoeconomic analysis
David Day MS RPh, Jane Brandman MS BPharm, Teresa Lubowski PharmD, Ambarish Ambegaonkar PhD, Kevin Livengood MS PharmD, Dolores Nobles-Knight PharmD, John Van Vleet PharmD & Cindy Yamaga PharmD
Pages: 107-115
Published online: 02 Dec 2008
AbstractforTherapy Cost 2000: a computer model for pharmacoeconomic analysis | References | PDF (64.5 KB)
  • 40 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Article
Bambuterol is a more cost-effective treatment strategy than salmeterol in asthmatic patients with nocturnal symptoms
Elisabeth Ståhl BSc, Klas Svensson MSc & Graham K Crompton MB ChB FRCP
Pages: 117-122
Published online: 02 Dec 2008
AbstractforBambuterol is a more cost-effective treatment strategy than salmeterol in asthmatic patients with nocturnal symptoms | References | PDF (59.8 KB)
  • 60 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access
Article
An economic comparison of the net clinical benefit and treatment costs of raltitrexed and 5-fluorouracil + leucovorin (Mayo regimen) in advanced colorectal cancer
David Kerr MD DSc FRCP & Kate M. O'Connor BSc
Pages: 123-132
Published online: 02 Dec 2008
AbstractforAn economic comparison of the net clinical benefit and treatment costs of raltitrexed and 5-fluorouracil + leucovorin (Mayo regimen) in advanced colorectal cancer | References | PDF (71.6 KB)
  • 52 Views
  • 6 CrossRef citations
  • 0Altmetric
Free Access
Article
The healthcare rationing debate: more clarity by separating the issues?
Konrad Obermann & David J Buck MSc
Pages: 133-141
Published online: 02 Dec 2008
AbstractforThe healthcare rationing debate: more clarity by separating the issues? | References | PDF (63.1 KB)
  • 63 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Article
The Cost of Obesity in the United Kingdom
D. Hughes PhD, A. McGuire PhD, H. Elliot MD, N. Finer MD, M.E.J. Lean MD, A. M. Prentice PhD & L. Ritchie MD
Pages: 143-153
Published online: 02 Dec 2008
AbstractforThe Cost of Obesity in the United Kingdom | References | PDF (68.5 KB)
  • 338 Views
  • 3 CrossRef citations
  • 0Altmetric
Free Access
Article
Cost-effectiveness of desirudin in the prevention of the thromboembolic complications of surgery
A Nicolaides & N Bosanquet
Pages: 155-166
Published online: 02 Dec 2008
AbstractforCost-effectiveness of desirudin in the prevention of the thromboembolic complications of surgery | References | PDF (96 KB)
  • 34 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access
Article
Mucodyne: the economics of preventing surgery for grommets
Ceri J. Phillips BSc(Econ) MSc(Econ) PhD, Anita Burrell BA(Econ) MA(Econ) MBA, R. Andrew Moore MA DPhil DSc, Grant J. Bates FRCSBSc & Dermot Commins FRCS (ORL)
Pages: 167-176
Published online: 02 Dec 2008
AbstractforMucodyne: the economics of preventing surgery for grommets | References | PDF (63.2 KB)
  • 104 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access

Explore articles

Explore the most recently published articles

The efficiency of TAVI in intermediate and low-risk Japanese patients.
Panagiotis Petrou
Editorial | Published online: 25 May 2024
Open Access
Cost-effectiveness of empagliflozin as add-on to standard of care for chronic kidney disease management in the United Kingdom
Mafalda Ramos et al.
Article | Published online: 17 May 2024
Open Access
Estimated impact and value of blood-based colorectal cancer screening at varied adherence compared with stool-based screening
John B. Kisiel et al.
Article | Published online: 13 May 2024
Open Access
Balancing innovation and ethics in AI governance for health technology assessment
João L. Carapinha et al.
Editorial | Published online: 13 May 2024
Open Access
View all latest articles